Toxic liver disease

K11_TOXLIV

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K71
  • Cause of death: ICD-10 K71

2 out of 7 registries used, show all original rules.

541

4. Check minimum number of events

None

541

5. Include endpoints

None

541

6. Filter based on genotype QC (FinnGen only)

541

Control definitions (FinnGen only)

Control exclude
K11_LIVER

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K70-K77
Name in latin
Morbus hepatis toxicus

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3897 2092 1772
Only index persons 3296 1812 1484
Unadjusted period prevalence (%)
Whole population 0.05 0.06 0.05
Only index persons 0.06 0.07 0.06
Median age at first event (years)
Whole population 56.47 57.86 54.71
Only index persons 55.21 56.21 53.98

-FinnGen-

Key figures

All Female Male
Number of individuals 541 314 227
Unadjusted period prevalence (%) 0.10 0.11 0.10
Median age at first event (years) 54.98 54.18 56.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
483
Matched controls
4832
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K71.2
ICD-10 Finland
Toxic liver disease with acute hepatitis
+∞
244.1
213
*
K71.9
ICD-10 Finland
Toxic liver disease, unspecified
1660.4
134.0
124
*
K71.0
ICD-10 Finland
Toxic liver disease with cholestasis
+∞
76.1
71
*
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
+∞
75.0
70
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
59.8
65.4
76
15
K76.9
ICD-10 Finland
Liver disease, unspecified
206.3
54.2
55
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
44.2
50.5
62
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.9
39.9
108
193
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
39.9
134
316
A05AA02
ATC
ursodeoxycholic acid; oral
41.7
39.6
49
13
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
32.2
39.6
52
18
K71.1
ICD-10 Finland
Toxic liver disease with hepatic necrosis
+∞
39.1
37
*
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
+∞
28.4
27
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
+∞
26.3
25
*
L04AX01
ATC
azathioprine; systemic
8.9
25.2
55
69
K71.6
ICD-10 Finland
Toxic liver disease with hepatitis, not elsewhere classified
+∞
24.2
23
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
+∞
22.0
21
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
+∞
19.9
19
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
+∞
19.9
19
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.7
19.1
90
279
N05CF01
ATC
zopiclone; oral
2.5
18.2
193
1018
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
17.6
171
859
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.4
17.5
36
41
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
17.4
237
1409
K71.3
ICD-10 Finland
Toxic liver disease with chronic persistent hepatitis
+∞
15.7
15
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
29.7
15.3
20
7
L04AA06
ATC
mycophenolic acid; systemic
12.4
15.2
27
23
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
+∞
14.7
14
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
+∞
14.7
14
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
37.3
14.5
18
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
14.4
123
564
H02AB06
ATC
prednisolone; systemic
2.1
14.3
250
1616
N05AH04
ATC
quetiapine; oral
2.8
14.3
105
442
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.8
14.0
47
106
ZX120
NOMESCO Finland
Intravenous
3.3
13.5
72
244
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
13.3
94
386
WX892
NOMESCO Finland
Monitored bed care
3.7
12.5
55
160
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
12.5
170
973
A06AD11
ATC
lactulose; oral
2.7
12.4
91
378
R94.5
ICD-10 Finland
Abnormal results of liver function studies
12.9
12.2
21
17
Z94.4
ICD-10 Finland
Liver transplant status
47.9
11.9
14
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.2
11.7
36
74
N05CD07
ATC
temazepam; oral
2.9
11.6
74
283
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
11.5
11
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
+∞
11.5
11
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
11.5
11
*
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
122.8
11.5
12
*
N07BB01
ATC
disulfiram; oral
4.5
11.4
40
95
D97
ICPC
Liver disease NOS
44.4
11.0
13
*
H02AB04
ATC
methylprednisolone; systemic
2.6
11.0
86
372
R50.9
ICD-10 Finland
Fever, unspecified
2.6
10.9
84
360
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.9
10.9
30
54
N06AX11
ATC
mirtazapine; oral
2.0
10.7
169
1013
K83.0
ICD-10 Finland
Cholangitis
13.3
10.7
18
14
N02AX02
ATC
tramadol; systemic, rectal
1.9
10.6
218
1446
K75.2
ICD-10 Finland
Nonspecific reactive hepatitis
+∞
10.5
10
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
10.4
34
75
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
9.9
10.3
20
21
C10AC01
ATC
colestyramine; oral
5.6
10.3
29
54
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.4
10.2
49
154
A02BC02
ATC
pantoprazole; systemic
1.9
10.2
317
2421
UJF32
NOMESCO Finland
Coloscopy
2.1
10.0
134
750
N05BA04
ATC
oxazepam; oral
2.1
10.0
135
758
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
17.2
9.9
15
9
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
9.8
71
292
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
9.8
91
428
A07EA06
ATC
budesonide; oral, local oral
5.1
9.8
30
62
127
Kela drug reimbursment
Transplant complication
9.4
9.6
19
21
N05BA01
ATC
diazepam; systemic, rectal
2.5
9.5
81
366
L04AD01
ATC
ciclosporin; systemic
7.8
9.5
21
28
Z3231
NOMESCO Finland
Registered nurse
2.0
9.4
143
837
K75.4
ICD-10 Finland
Autoimmune hepatitis
+∞
9.4
9
*
C03DA01
ATC
spironolactone; oral
2.8
9.4
61
235
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.3
9.3
24
40
N05AH03
ATC
olanzapine; systemic
3.6
9.3
42
126
ZXD05
NOMESCO Finland
Urgent procedure
1.9
9.3
157
957
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
9.2
64
257
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
8.8
50
177
H02AB07
ATC
prednisone; oral
2.4
8.6
78
363
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.8
8.6
57
223
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
8.5
45
153
K70.0
ICD-10 Finland
Alcoholic fatty liver
91.6
8.4
9
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
13.1
8.4
14
11
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.4
177
1158
K71.8
ICD-10 Finland
Toxic liver disease with other disorders of liver
+∞
8.4
8
*
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
+∞
8.4
8
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
8.2
72
327
K85
ICD-10 Finland
Acute pancreatitis
7.7
8.2
18
24
UJK02
NOMESCO Finland
ERCP
6.0
8.1
21
36
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
8.1
39
124
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
8.0
118
675
C03CA01
ATC
furosemide; systemic
1.9
8.0
136
824
N06AX12
ATC
bupropion; oral
3.4
8.0
38
119
R53
ICD-10 Finland
Malaise and fatigue
2.0
7.9
110
617
ZXE00
NOMESCO Finland
One hour or less
1.8
7.8
189
1287
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
7.4
51
205
N06AB04
ATC
citalopram; systemic
2.0
7.4
108
616
K71.4
ICD-10 Finland
Toxic liver disease with chronic lobular hepatitis
+∞
7.3
7
*
K71.7
ICD-10 Finland
Toxic liver disease with fibrosis and cirrhosis of liver
+∞
7.3
7
*
JJ5AT
NOMESCO Finland
NA
+∞
7.3
7
*
N03AX16
ATC
pregabalin; oral
1.9
7.3
119
705
L04AA01
ATC
[U] ciclosporin; systemic
7.5
7.2
16
22
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.2
85
444
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.2
178
1211
TK800
NOMESCO Finland
Hemodialysis
5.2
7.2
21
42
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.1
113
664
J01MA12
ATC
levofloxacin; systemic
2.0
7.1
92
502
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.9
7.0
27
72
ZY010
NOMESCO Finland
Hospital outpatient
3.4
6.8
32
100
M05BA04
ATC
alendronic acid; oral
2.7
6.8
44
170
K83.1
ICD-10 Finland
Obstruction of bile duct
9.5
6.8
13
14
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.8
6.8
18
32
C07AA05
ATC
propranolol; systemic
1.9
6.8
99
564
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.8
6.8
21
45
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
40.6
6.8
8
*
A02BC05
ATC
esomeprazole; systemic
1.7
6.7
190
1342
N05AX12
ATC
aripiprazole; systemic
3.7
6.6
27
76
K92.0
ICD-10 Finland
Haematemesis
5.5
6.5
18
34
N03AE01
ATC
clonazepam; systemic
3.1
6.5
34
116
A07EC02
ATC
mesalazine; oral, rectal
3.1
6.5
34
116
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
6.5
74
381
K76.89
ICD-10 Finland
Other specified diseases of liver
70.7
6.4
7
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
6.4
29
89
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.4
6.3
12
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.3
61
294
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
6.3
56
259
K71.5
ICD-10 Finland
Toxic liver disease with chronic active hepatitis
+∞
6.3
6
*
K72.1
ICD-10 Finland
Chronic hepatic failure
+∞
6.3
6
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
6.2
62
301
R4110
NOMESCO Finland
Physiotherapy
1.8
6.2
133
858
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
6.2
35
123
F05.9
ICD-10 Finland
Delirium, unspecified
5.9
6.2
16
28
P76
ICPC
Depressive disorder
3.0
6.2
35
124
L88
ICPC
Rheumatoid/seropositive arthritis
3.8
6.2
24
65
P01BA02
ATC
hydroxychloroquine; oral
2.5
6.2
46
193
L04AA13
ATC
leflunomide; oral
4.5
6.1
20
46
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.7
6.0
16
29
WX882
NOMESCO Finland
High dependency care
4.7
6.0
19
42
Z2446
NOMESCO Finland
Social worker
2.8
6.0
36
134

Mortality – FinRegistry

Association

Association between endpoint K11_TOXLIV and mortality.

Females

Parameter HR [95% CI] p-value
K11_TOXLIV 2.305 [1.95, 2.72] < 0.001
Birth year 0.995 [0.99, 1.0] 0.287

During the follow-up period (1.1.1998 — 31.12.2019), 482 out of 1710 females with K11_TOXLIV died.

Males

Parameter HR [95% CI] p-value
K11_TOXLIV 3.07 [2.52, 3.74] < 0.001
Birth year 0.99 [0.98, 1.0] 0.036

During the follow-up period (1.1.1998 — 31.12.2019), 519 out of 1402 males with K11_TOXLIV died.

Mortality risk

Mortality risk for people of age

years, who have K11_TOXLIV.

N-year risk Females Males
1 0.296% 0.643%
5 1.451% 3.723%
10 3.399% 8.851%
15 6.4% 17.475%
20 11.149% 28.193%

Relationships between endpoints

Index endpoint: K11_TOXLIV – Toxic liver disease

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data